Brent B Saetrum, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 5000 Hopyard Road, Pleasanton, WA 94588 Phone: 925-251-6917 Fax: 925-924-0506 |
News Archive
Researchers have developed a novel platform to more accurately detect and identify the presence and severity of peanut allergies, without directly exposing patients to the allergen, according to a new study published in the journal Scientific Reports.
With new variants of SARS-CoV-2 emerging, the COVID-19 pandemic is far from over. While the global vaccine rollout has moved at an impressive speed, the search for new safe, effective, and targeted therapies is still on. Now, a new study reviews the potential for curcumin, a natural alkaloid derived from turmeric, and nanosystems to treat COVID-19.
Following a May 15, 2014, meeting with the U.S. Food and Drug Administration (FDA), Shire plc, the global specialty biopharmaceutical company, announces today that it intends to submit a New Drug Application for lifitegrast as a treatment for the signs and symptoms of dry eye disease in adults in the first-quarter 2015, as we complete remaining chemistry and manufacturing work.
3Care Therapeutics, a manufacturer of nutritional supplements for treating common chronic health problems, announces the release of the 3Care BioSystems Program, a simplified nutritional program that helps practitioners improve patients' health and achieve thriving nutrition practices. The Program is administered via a free, easy-to-use software application; and unlike more complicated therapeutic lifestyle change programs, the 3Care Program encourages improved health outcomes through better patient compliance.
Babesiosis, a rare and occasionally fatal tick-borne disease caused by microscopic parasites known as Babesia which infect red blood cells, is on the rise in the Lower Hudson Valley according to the NYS DOH, including the counties of Westchester, Putnam, Orange, Dutchess, Ulster, Sullivan and Rockland.
› Verified 9 days ago